METHODS FOR TREATING CD20-POSITIVE PROLIFERATIVE DISORDER WITH MOSUNETUZUMAB AND POLATUZUMAB VEDOTIN

To provide methods for treating subjects having a CD20-positive cell proliferative disorder.SOLUTION: The invention pertains to the treatment of subjects having a CD20-positive cell proliferative disorder by administering a combination of mosunetuzumab and polatuzumab vedotin.SELECTED DRAWING: Figur...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	IRIS TRANTHUYNGAN TO, OKI YASUHIRO, CAROL ELAINE O'HEAR
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide methods for treating subjects having a CD20-positive cell proliferative disorder.SOLUTION: The invention pertains to the treatment of subjects having a CD20-positive cell proliferative disorder by administering a combination of mosunetuzumab and polatuzumab vedotin.SELECTED DRAWING: Figure 2A 【課題】ＣＤ２０陽性細胞増殖性障害を有する対象を処置する方法を提供する。【解決手段】モスネツズマブおよびポラツズマブベドチンの組み合わせを投与する。【選択図】図２Ａ